Medtech

Aalto Bio to receive war chest for M&A deals as firm is acquired

The medtech company provides raw materials, including proteins, antigens and antibodies, to the global diagnostics sector

Philip Noone, the managing director of Aalto Bio, which provides raw materials to the global diagnostics sector, said the company’s ‘ultimate goal is to become the global provider of critical raw materials for diagnostics and vaccine development’. Picture: Terry McDonagh